Following USNA's presentation at last week's Sidoti & Co. investor conference, we argue that management is taking the appropriate steps to revive its core direct selling segment through changes in its commercial strategy and its recently enhanced compensation plan. We also expect further revenue gains at Hiya due in part to sales channel expansion beyond its core subscriber base business. As we see it, the company's plans to bring Hiya's manufacturing in-house will aid operating margin expansion, as will USNA's rightsizing of the business through various cost cuts. However, with some of these cost savings likely to be offset by investments into Hiya's growth plans and for the core business, we reduce our 2026 EPS forecast by $0.20 to $1.90, still anticipating EPS growth to resume in 2H:26 and continue in 2027. In our view, a solid, debt free balance sheet ($7.95 per share in cash at the end of 3Q:25) positions the company well to pursue potential additional acquisitions in the health and wellness sector (not included in our financial forecasts). Our $39 price target is based on 14x our 2027 EPS estimate of $2.76. Our moderate risk rating on USNA factors in the company's solid balance sheet and good free cash flow generation.